Krebs Biochemicals & Industries Limited: Merger
Krebs Biochemicals & Industries Limited is merging into Ipca Laboratories Limited; 7 shares of Ipca Laboratories Limited for every 200 shares of Krebs Biochemi…
Terms
Each figure links to its source- Swap ratio
- 7 shares of Ipca Laboratories Limited for every 200 shares of Krebs Biochemicals & Industries Limited
- Appointed date
- Not known: Not yet stated in a filing
- Record date
- Not known: Not yet stated in a filing
- Effective date
- Not known: Not yet stated in a filing
- Merging company
- Krebs Biochemicals & Industries Limited
- Surviving company
- Ipca Laboratories Limited
Timeline
12 steps- Board approval26 Jun 2026
- Draft scheme filed with the exchanges6 Jul 2026
- Exchange observation letter2 Nov 2026
9 more steps, each with its date and filing. Free with a Google sign-in.
Sign in with GoogleSource documents
12 filings12 filings from the exchanges and SEBI, with links. Free with a Google sign-in.
Sign in with GoogleWhat this means for a shareholder
In a merger by scheme of arrangement, shareholders of the merging company receive shares of the surviving company at a fixed swap ratio. The scheme needs the exchanges’ observation letter, approval of shareholders and creditors, and the NCLT’s sanction before it takes effect.
Shareholders on the register on the record date receive the new shares; the merging company’s shares stop trading shortly before it.
Updated 19:38 IST · Information from public filings. Not investment advice.